logo-loader
viewMucpharm Pty Ltd

Mucpharm focusing on treating mucin-containing cancers

Mucpharm Chief Medical Officer David Morris sat down with Proactive’s Christine Corrado at the BIO CEO & Investor Conference in New York. The Sydney, Australia- based, privately-held, specialized oncology company is focused on treating mucin-containing and secreting cancers.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Perseus Mining reports 'minimal impact' from coronavirus but is well placed...

Perseus Mining Limited's (ASX:PRU) Jeff Quartermaine talks Proactive's Andrew Scott through their planning for COVID-19 and how they're 'well-positioned' to deal with the outbreak.  He says they're adapting its activities around the current pandemic using systems developed during the...

1 day, 12 hours ago

2 min read